Physician profile
Robert J Marx
NPI 1073576351
$3,348.18
in general payments reported to CMS, 2019-2025
7 companies · $647 in 2025
The $647 reported for 2025 was more than what 87% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $21.15 · 2021: $738 · 2022: $549 · 2023: $488 · 2024: $649 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,783.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,427.93 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $400.42 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $124.99 | 2022 | |
| Lilly USA, LLC | $124.99 | 2025 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.68 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $120.20 | 2021 | |
| Exact Sciences Corporation | $24.97 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Marx listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.